We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$2.34B
AUM Growth
-$1.52B
Cap. Flow
-$1.58B
Cap. Flow %
-67.74%
Top 10 Hldgs %
43.48%
Holding
80
New
9
Increased
13
Reduced
27
Closed
18

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$115M
2
VTRS icon
Viatris
VTRS
+$114M
3
MGNI icon
Magnite
MGNI
+$24.6M
4
NRG icon
NRG Energy
NRG
+$23.4M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$15.4M

Sector Composition

Rank Sector Weight
1 Healthcare 33.22%
2 Energy 14.33%
3 Industrials 13.82%
4 Financials 10.76%
5 Utilities 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
1
Teva Pharmaceuticals
TEVA
$40.9B
$141M 6.03%
18,718,362
+14,218,556
+316% +$115M
GLNG icon
2
Golar LNG
GLNG
$5.13B
$130M 5.57%
6,456,757
-14,022
-0.2% -$301K
VTRS icon
3
Viatris
VTRS
$19.3B
$119M 5.1%
+11,950,000
New +$114M
HTZ icon
4
Hertz
HTZ
$692M
$105M 4.5%
5,720,890
-759,933
-12% -$12.5M
FLR icon
5
Fluor
FLR
$8B
$101M 4.32%
3,414,349
+146,746
+4% +$4.21M
COOP
6
DELISTED
Mr. Cooper
COOP
$99.5M 4.26%
1,965,173
+227,135
+13% +$10.4M
BGC icon
7
BGC Group
BGC
$4.95B
$88.6M 3.79%
20,000,000
+146,851
+0.7% +$651K
CCJ icon
8
Cameco
CCJ
$42.2B
$84.4M 3.61%
2,695,004
-1,995,890
-43% -$56.1M
VST icon
9
Vistra
VST
$47.3B
$73.8M 3.16%
2,813,221
+352,556
+14% +$8.61M
COLL icon
10
Collegium Pharmaceutical
COLL
$931M
$73.6M 3.15%
3,425,000
+150,832
+5% +$3.42M
PARR icon
11
Par Pacific Holdings
PARR
$3.46B
$71.7M 3.07%
2,694,210
-205,732
-7% -$4.86M
AIR icon
12
AAR Corp
AIR
$5.73B
$71M 3.03%
1,228,422
-234,920
-16% -$12.7M
PLYA
13
DELISTED
Playa Hotels & Resorts
PLYA
$58.7M 2.51%
7,208,296
-2,298,988
-24% -$20.9M
MATV icon
14
Mativ Holdings
MATV
$703M
$52M 2.22%
3,437,578
+184,475
+6% +$3.27M
HAPN
15
Happen Inc
HAPN
$2.26B
$51.8M 2.21%
5,308,472
-184,123
-3% -$1.48M
ADEA icon
16
Adeia
ADEA
$3.12B
$50.6M 2.16%
4,592,561
XPER icon
17
Xperi
XPER
$343M
$50.5M 2.16%
3,843,744
DOLE icon
18
Dole
DOLE
$1.32B
$49.2M 2.1%
3,637,678
-1,105,598
-23% -$14.2M
STNG icon
19
Scorpio Tankers
STNG
$3.77B
$48.8M 2.09%
1,033,271
-1,371,296
-57% -$67.8M
KNSA icon
20
Kiniksa Pharmaceuticals
KNSA
$5.92B
$47.6M 2.03%
3,378,164
+602,528
+22% +$8.06M
ARQT icon
21
Arcutis Biotherapeutics
ARQT
$3.22B
$46.5M 1.99%
4,884,530
+1,384,530
+40% +$15.4M
ANIP icon
22
ANI Pharmaceuticals
ANIP
$1.76B
$45.6M 1.95%
847,011
+198,970
+31% +$8.82M
RNW icon
23
ReNew
RNW
$2.27B
$44.7M 1.91%
8,165,905
OFIX icon
24
Orthofix Medical
OFIX
$420M
$43.2M 1.85%
2,392,412
+348,698
+17% +$6.51M
CSTM icon
25
Constellium
CSTM
$4.02B
$38.3M 1.64%
2,224,654
-765,912
-26% -$11.7M

Similar funds

Rubric Capital Management (New York)'s Q2 2023 Portfolio in Review

As of Q2 2023, Rubric Capital Management (New York) held 80 positions worth $2.34B, down 39% from $3.86B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Rubric Capital Management (New York) withdrew a net $1.58B in Q2 2023, closing 18 positions and reducing 27 holdings. Its most notable exit was First Citizens BancShares, an estimated $51.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 16% a quarter earlier, followed by Energy and Industrials.

Against the trend, Rubric Capital Management (New York) opened a new position in Viatris worth $119M.

  • Rubric Capital Management (New York)'s largest Q2 2023 buy was Viatris: 11,950,000 shares worth $119M.
  • Rubric Capital Management (New York) added most to Teva Pharmaceuticals in Q2 2023, an estimated $115M increase.
  • Rubric Capital Management (New York)'s biggest Q2 2023 reduction was Scorpio Tankers, cutting an estimated $67.8M.
  • Rubric Capital Management (New York) fully exited First Citizens BancShares in Q2 2023, selling an estimated $51.6M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 43% of its $2.34B portfolio in Q2 2023.
  • Rubric Capital Management (New York) opened 9 new positions and closed 18 in Q2 2023.
  • Rubric Capital Management (New York)'s portfolio value fell 39% quarter-over-quarter to $2.34B.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2023, filed 11 Aug 2023.